Skip to main content
logo
CSL Limited (CSLLY)
OTCMKTS · Delayed Price · Currency is USD
58.82
-0.90 (-1.51%)
At close: Dec 16, 2025

Revenue Breakdown

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 2012 - 2021
Sales and Service Revenue (USD)
15.04B
Log In
Log In
Log In
Upgrade
Influenza Pandemic Facility Reservation Fees (USD)
179.00M
Log In
Log In
Log In
Upgrade
Royalties and License Revenue (USD)
216.00M
Log In
Log In
Log In
Upgrade
Other Income (USD)
128.00M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 2012 - 2021
CSL Behring Revenue (USD)
11.16B
Log In
Log In
Log In
Upgrade
CSL Seqirus Revenue (USD)
2.17B
Log In
Log In
Log In
Upgrade
CSL Vitor Revenue (USD)
2.23B
Log In
Log In
Log In
Upgrade

Gross Profit

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 2012 - 2021
CSL Behring Segment Gross Profit (USD)
5.64B
Log In
Log In
Log In
Upgrade
CSL Seqirus Segment Gross Profit (USD)
1.26B
Log In
Log In
Log In
Upgrade
CSL Vitor Segment Gross Profit (USD)
1.55B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 2012 - 2021
CSL Behring Segment EBIT (USD)
-
Log In
Log In
Log In
Upgrade
CSL Seqirus Segment EBIT (USD)
-
Log In
Log In
Log In
Upgrade

Adjusted EBIT

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 2012 - 2021
CSL Behring Segment Operating Result (USD)
4.70B
Log In
Log In
Log In
Upgrade
CSL Seqirus Segment Operating Result (USD)
1.03B
Log In
Log In
Log In
Upgrade
CSL Vitor Segment Operating Result (USD)
1.10B
Log In
Log In
Log In
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai.